Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,084 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE).
Prajapati HJ, Spivey JR, Hanish SI, El-Rayes BF, Kauh JS, Chen Z, Kim HS. Prajapati HJ, et al. Among authors: kim hs. Ann Oncol. 2013 Apr;24(4):965-73. doi: 10.1093/annonc/mds605. Epub 2012 Dec 5. Ann Oncol. 2013. PMID: 23223331 Free article. Clinical Trial.
Safety and efficacy of a circumferential clip-based vascular closure device in cirrhotic and coagulopathic patients with hepatocellular carcinoma after doxorubicin drug-eluting beads transarterial chemoembolization.
Prajapati HJ, Rafi S, Edalat F, Kooby DA, Kim HS. Prajapati HJ, et al. Among authors: kim hs. Cardiovasc Intervent Radiol. 2014 Jun;37(3):664-70. doi: 10.1007/s00270-013-0709-9. Epub 2013 Aug 10. Cardiovasc Intervent Radiol. 2014. PMID: 23934114
16,084 results
You have reached the last available page of results. Please see the User Guide for more information.